Komori
Human Metabolome Technologies (6090) · RiskMaterialised

Impairment Loss on Equipment Used in the Biomarker Business

First written in FY2020. 3 of 3 entries say "Materialised", first in FY2020. Latest entry: FY2022.

3entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2020 – FY20222020: 120202021: 120212022: 12022
Same theme, other companies
Impairment of HealthTech Business AssetsA theme 3 companies write about · 3 as a headwind · 0 as a tailwind

Human Metabolome Technologies moved to the "Worse" side of this theme in 2020.

1 other company's latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2022MaterialisedAnnual report

    「Chuo-ku, Tokyo | Measurement equipment for testing | Tools, furniture and fixtures | ¥248 thousand」

    The Company recognized an impairment loss of ¥248 thousand on measurement equipment for testing in Chuo-ku, Tokyo, related to the healthcare solutions business.
  2. FY2021MaterialisedAnnual report

    「Chuo-ku, Tokyo | Measurement equipment for testing | Software | ¥428 thousand」

    The Company recognized an impairment loss of ¥428 thousand on software for measurement equipment for testing because recovery through future cash flows was not expected.
  3. FY2020MaterialisedAnnual report

    「Following a review of the future outlook, the Company recognized the full carrying amount as an impairment loss under extraordinary losses because recovery through future cash flows was not expected.」

    The Company recognized an impairment loss of ¥14.050 million on building fixtures and other assets used in the biomarker business in Yokohama, Kanagawa Prefecture.
Moved together

"Uncertainty in the Global Economy Due to the Slowdown in Emerging Markets, the UK's Withdrawal from the EU and Other Factors" moved the same way as this thread, in the same document, in 3 of its 3 moves.

332222★123456
  1. ★This thread
  2. 1Uncertainty in the Global Economy Due to the Slowdown in Emerging Markets, the UK's Withdrawal from the EU and Other Factors3×
  3. 2Factors contributing to instability in the domestic economy, including yen appreciation and falling share prices3×
  4. 3Further Penetration of Overseas Markets and Winning Orders in Asia2×
  5. 4Establishing the World’s Leading Metabolome Analysis Technology and Innovative Diagnostic Methods2×
  6. 5Increase in domestic and overseas competition in metabolomics analysis2×
  7. 6Impairment loss on certain product plans in the metabolomics business2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Human Metabolome Technologies yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impairment Loss on Equipment Used in the Biomarker Business | Human Metabolome Technologies,Inc. (6090) | Komori